TW202428309A - 澱粉素受體促效劑 - Google Patents

澱粉素受體促效劑 Download PDF

Info

Publication number
TW202428309A
TW202428309A TW112150026A TW112150026A TW202428309A TW 202428309 A TW202428309 A TW 202428309A TW 112150026 A TW112150026 A TW 112150026A TW 112150026 A TW112150026 A TW 112150026A TW 202428309 A TW202428309 A TW 202428309A
Authority
TW
Taiwan
Prior art keywords
compound
receptor agonist
peptide
starch
amylin
Prior art date
Application number
TW112150026A
Other languages
English (en)
Chinese (zh)
Inventor
賽西利 米雅 喬根森
湯瑪斯 克魯斯
賈斯佩 F 勞
Original Assignee
丹麥商諾佛 儂迪克股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US18/512,512 external-priority patent/US12116388B2/en
Application filed by 丹麥商諾佛 儂迪克股份有限公司 filed Critical 丹麥商諾佛 儂迪克股份有限公司
Publication of TW202428309A publication Critical patent/TW202428309A/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/605Glucagons
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72Receptors; Cell surface antigens; Cell surface determinants for hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
TW112150026A 2022-12-22 2023-12-21 澱粉素受體促效劑 TW202428309A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP22215958.4 2022-12-22
EP22215958 2022-12-22
US18/512,512 2023-11-17
US18/512,512 US12116388B2 (en) 2022-12-22 2023-11-17 Amylin receptor agonists

Publications (1)

Publication Number Publication Date
TW202428309A true TW202428309A (zh) 2024-07-16

Family

ID=89542238

Family Applications (1)

Application Number Title Priority Date Filing Date
TW112150026A TW202428309A (zh) 2022-12-22 2023-12-21 澱粉素受體促效劑

Country Status (12)

Country Link
EP (1) EP4638480A1 (https=)
JP (1) JP2025542410A (https=)
KR (1) KR20250127104A (https=)
CN (1) CN120435491A (https=)
AU (1) AU2023411346A1 (https=)
CL (1) CL2025001805A1 (https=)
CO (1) CO2025008319A2 (https=)
IL (1) IL321586A (https=)
JO (1) JOP20250144A1 (https=)
MX (1) MX2025007124A (https=)
TW (1) TW202428309A (https=)
WO (1) WO2024133739A1 (https=)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994008006A1 (en) 1992-09-30 1994-04-14 Zymogenetics, Inc. Human calcitonin receptor
ES2401965T3 (es) 2009-02-19 2013-04-25 Novo Nordisk A/S Modificación de Factor VIII
JP6121992B2 (ja) 2011-06-10 2017-04-26 ノヴォ ノルディスク アー/エス ポリペプチド
AR097701A1 (es) * 2013-09-19 2016-04-13 Zealand Pharma As Análogos de amilina
JP6898518B2 (ja) 2018-02-02 2021-07-07 ノヴォ ノルディスク アー/エス Glp−1アゴニスト、n−(8−(2−ヒドロキシベンゾイル)アミノ)カプリル酸の塩及び滑沢剤を含む固形組成物
TWI829687B (zh) 2018-05-07 2024-01-21 丹麥商諾佛 儂迪克股份有限公司 包含glp-1促效劑與n-(8-(2-羥基苯甲醯基)胺基)辛酸之鹽的固體組成物

Also Published As

Publication number Publication date
KR20250127104A (ko) 2025-08-26
CN120435491A (zh) 2025-08-05
EP4638480A1 (en) 2025-10-29
CO2025008319A2 (es) 2025-07-17
CL2025001805A1 (es) 2025-09-26
MX2025007124A (es) 2025-07-01
JP2025542410A (ja) 2025-12-25
IL321586A (en) 2025-08-01
AU2023411346A1 (en) 2025-07-24
WO2024133739A1 (en) 2024-06-27
JOP20250144A1 (ar) 2025-06-16

Similar Documents

Publication Publication Date Title
TWI850611B (zh) Glp-1及澱粉素受體之共促效劑
TWI810606B (zh) Gip/glp1共促效劑化合物
TWI707865B (zh) Gip衍生物及其用途
US10005824B2 (en) Selective PYY compounds and uses thereof
EP3068421B1 (en) Selective pyy compounds and uses thereof
TW201542588A (zh) 糊精類似物
US12116388B2 (en) Amylin receptor agonists
TW202428309A (zh) 澱粉素受體促效劑
JP7755031B2 (ja) Glp-1、gip、およびアミリン受容体の三重作動薬